Skip to content
Lawsuit Help Desk

Lawsuit News Center

Breaking the Cancer Code: The Astounding Rise of Precision Oncology and the Fight for Equality in Clinical Trials

Breaking the Cancer Code: The Astounding Rise of Precision Oncology and the Fight for Equality in Clinical Trials

Precision oncology's rapid growth and impact on cancer treatment is remarkable. Bolstered by improved genetic understanding, these targeted therapies have increased eligible patients almost twofold from 2017 to 2022, offering new hope through specific genetic alteration treatment. This shift is largely due to nearly half of all oncology drugs approved since 1998 being precision therapies.

However, racial and ethnic minority underrepresentation taints this scientific leap. There's a pressing need to ensure equal access to sophisticated healthcare in the battle against cancer. Racial inequality in palliative care, structural racism in healthcare, and minority reluctance to partake in clinical trials are issues requiring urgent attention. As we enter an era defined by precision oncology's immense power, tackling these systemic barriers is vital for a true revolution in cancer treatment.

Full article here: https://ipllfirm.com/all-insights/news-and-articles/breaking-the-cancer-code-the-astounding-rise-of-precision-oncology-and-the-fight-for-equality-in-clinical-trials/